4891 - 4900 of 9117 Results
Title
Year
- The Parkinson's Progression Markers Initiative: Why Then? Why Now?2026RESTRICTEDTitle: The Parkinson's Progression Markers Initiative: Why Then? Why Now?Journal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78192Citation Count: 0
- Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI2026RESTRICTEDTitle: Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78230Citation Count: 0
-
OPENTitle: Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicityJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 11Start Page: 963End Page: 963Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-020-03172-8Best OA location URL: https://www.nature.com/articles/s41419-020-03172-8.pdfCitation Count: 26
-
OPENTitle: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainJournal Name: Molecular Therapy - Methods & Clinical DevelopmentPublisher: Elsevier BVVol: 11Issue #:Start Page: 29End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008Best OA location URL: http://www.cell.com/article/S2329050118300895/pdfCitation Count: 20
- Leucine‐rich repeat kinase 2‐sensitive Na + /Ca 2+ exchanger activity in dendritic cells2015RESTRICTEDTitle: Leucine‐rich repeat kinase 2‐sensitive Na + /Ca 2+ exchanger activity in dendritic cellsJournal Name: The FASEB JournalPublisher: WileyVol: 29Issue #: 5Start Page: 1701End Page: 1710Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.14-264028Citation Count: 19
- Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriers2018OPENTitle: Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriersJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 966End Page: 973Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27342Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6105406Citation Count: 54
-
OPENTitle: Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 43Issue #: 7Start Page: 604End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12402Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5632188Citation Count: 66
-
OPENTitle: GBA1 mutations as a role model for precision medicine in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01505-6Best OA location URL: https://www.nature.com/articles/s41531-026-01505-6_reference.pdfCitation Count: 0
-
RESTRICTEDTitle: Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degenerationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1227End Page: 1231Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.027Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.08.027Citation Count: 26
- Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens2019RESTRICTEDTitle: Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimensJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1929End Page: 1930Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27891Citation Count: 5